Detalhe da pesquisa
1.
A randomized phase II trial to examine modified vaccinia Ankara-5T4 vaccine in patients with relapsed asymptomatic ovarian cancer (TRIOC).
Int J Gynecol Cancer
; 2024 May 17.
Artigo
Inglês
| MEDLINE | ID: mdl-38760075
2.
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial.
Lancet Oncol
; 23(7): 919-930, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35690073
3.
Objective responses to first-line neoadjuvant carboplatin-paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trial.
Lancet Oncol
; 22(2): 277-288, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33357510
4.
A phase 2 study of anastrozole in patients with oestrogen receptor and/progesterone receptor positive recurrent/metastatic granulosa cell tumours/sex-cord stromal tumours of the ovary: The PARAGON/ANZGOG 0903 trial.
Gynecol Oncol
; 163(1): 72-78, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34412908
5.
Weekly platinum-based chemotherapy versus 3-weekly platinum-based chemotherapy for newly diagnosed ovarian cancer (ICON8): quality-of-life results of a phase 3, randomised, controlled trial.
Lancet Oncol
; 21(7): 969-977, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32615110
6.
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial.
Lancet
; 394(10214): 2084-2095, 2019 12 07.
Artigo
Inglês
| MEDLINE | ID: mdl-31791688
7.
Real world outcomes in platinum sensitive relapsed ovarian, fallopian tube, or peritoneal cancer treated in routine clinical practice in the United Kingdom prior to poly-ADP ribose polymerase inhibitors.
Int J Gynecol Cancer
; 30(7): 1026-1033, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32321768
8.
Phase 2 study of anastrozole in recurrent estrogen (ER)/progesterone (PR) positive endometrial cancer: The PARAGON trial - ANZGOG 0903.
Gynecol Oncol
; 154(1): 29-37, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-31130288
9.
An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor.
Gynecol Oncol
; 153(3): 541-548, 2019 06.
Artigo
Inglês
| MEDLINE | ID: mdl-31005287
10.
Cediranib combined with carboplatin and paclitaxel in patients with metastatic or recurrent cervical cancer (CIRCCa): a randomised, double-blind, placebo-controlled phase 2 trial.
Lancet Oncol
; 16(15): 1515-1524, 2015 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-26474517
11.
CYP3A genetic variation and taxane-induced peripheral neuropathy: a systematic review, meta-analysis, and candidate gene study.
Front Pharmacol
; 14: 1178421, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37469869
12.
Corrigendum: CYP3A genetic variation and taxane-induced peripheral neuropathy: a systematic review, meta-analysis, and candidate gene study.
Front Pharmacol
; 14: 1274075, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37719864
13.
Ad hoc Analysis of the Phase III ENGOT-OV16/NOVA Study: Niraparib Efficacy in Germline BRCA Wild-type Recurrent Ovarian Cancer with Homologous Recombination Repair Defects.
Cancer Res Commun
; 2(11): 1436-1444, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36970052
14.
Two distinct clinical patterns of checkpoint inhibitor-induced thyroid dysfunction.
Endocr Connect
; 9(4): 318-325, 2020 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-32163916
15.
Anti-epidermal growth factor receptor antibodies in the treatment of metastatic colorectal cancer.
Recent Pat Anticancer Drug Discov
; 5(2): 142-51, 2010 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-19954416